Trusted medical expertise in seconds.

Access 1,000+ clinical and preclinical articles. Find answers fast with the high-powered search feature and clinical tools.

Try free for 5 days
Evidence-based content, created and peer-reviewed by physicians. Read the disclaimer.

Staphylococcal diseases

Last updated: April 29, 2021

Summarytoggle arrow icon

Staphylococci are gram-positive, spherical-shaped bacteria that form clusters and are commonly found on the skin and mucous membranes. Clinically, the most important species include Staphylococcus aureus and Staphylococcus epidermidis, which are categorized according to their coagulase activity. S. aureus is coagulase positive and expresses several virulence factors which support evasion of the host immune response. S. epidermidis is coagulase negative and is usually less virulent, although it can evade the host immune system by forming and subsequently hiding in a biofilm. S. aureus is commonly responsible for many localized infections (e.g., folliculitis, cervical lymphadenopathy) and also severe organ infections in the setting of bacteremia (e.g., endocarditis, osteomyelitis). As a toxin producer, S. aureus can cause food poisoning (see Staphylococcal food poisoning) and, in severe cases, life-threatening diseases such as staphylococcal scalded skin syndrome (SSSS) or toxic shock syndrome (TSS). Methicillin-resistant S. aureus (MRSA), in particular, poses a major threat to both immunocompromised and multimorbid patients and is a considerable challenge to hospital hygiene. S. epidermidis is mostly responsible for foreign body infections caused by, for example, contaminated peripheral lines or prosthetic joints. The treatment of choice is anti-staphylococcal penicillins (e.g., oxacillin, flucloxacillin) or first and second-generation cephalosporins.

Staphylococci are immotile, gram-positive bacteria that have a round shape and are found in clusters.

  • Approx. 30% of the general human population are long-term carriers of S. aureus. [1]
    • Three patterns of carriage have been observed: 20% are permanent carriers, 60% are intermittent carriers, 20% are noncarriers
    • MRSA carrier rates and invasive infections have increased during the last decades.

Epidemiological data refers to the US, unless otherwise specified.

Staphylococcus aureus

For more information, see methicillin-resistant Staphylococcus aureus and “Gram-positive cocci” section in the bacteria overview.

Staphylococcus epidermidis

Staphylococcus aureus

Coagulase-negative staphylococcus (particularly S. epidermidis)


Ear, nose, and throat

Lymphatic system

Systemic infections

Staphylococci are the most common causative pathogen of infective endocarditis!

Foreign body infections

Toxin-mediated diseases

  1. Tong SYC, Davis JS, Eichenberger E, Holland TL, Fowler VG. Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management. Clin Microbiol Rev. 2015; 28 (3): p.603-661. doi: 10.1128/cmr.00134-14 . | Open in Read by QxMD
  2. Xu SX, McCormick JK. Staphylococcal superantigens in colonization and disease. Frontiers in Cellular and Infection Microbiology. 2012; 2 . doi: 10.3389/fcimb.2012.00052 . | Open in Read by QxMD
  3. Ghasemian A, Najar Peerayeh S, Bakhshi B, Mirzaee M. The Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMMs) Genes among Clinical Isolates of Staphylococcus aureus from Hospitalized Children.. Iranian journal of pathology. 2015; 10 (4): p.258-64.
  4. Herold G. Internal Medicine. Herold G ; 2014